tm logo
ZELIRA
REGISTERED

on 26 Apr 2023

Last Applicant/ Owned by

ZELIRA THERAPEUTICS LIMITED

Level 3,101 St Georges TerracePerth WA 6000

AU

Serial Number

2017034 filed on 09th Jan 2020

Registration Number

TMA1177078 registered on 26th Apr 2023

Registration expiry Date

09th Jan 2030

Correspondent Address

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

ZELIRA

Trademark usage description

medical cannabis, none of the goods being for the treatment and detection of cervical cancer and related infections; medical preparations derived from Read More

Classification Information


Class [005]
Medical cannabis, none of the goods being for the treatment and detection of cervical cancer and related infections; Medical preparations derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, epilepsy, arthritis, Crohn's Disease, insomnia, diabetes, eczema, psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder, none of the goods being for the treatment and detection of cervical cancer and related infections; medicinal plant extracts and medicinal herbs derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, epilepsy, arthritis, Crohn's Disease, insomnia, diabetes, eczema, psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder, none of the goods being for the treatment and detection of cervical cancer and related infections; medicinal oils derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, epilepsy, arthritis, Crohn's Disease, insomnia, diabetes, eczema, psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder, none of the goods being for the treatment and detection of cervical cancer and related infections; herbal preparations for medical purposes derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, epilepsy, arthritis, Crohn's Disease, insomnia, diabetes, eczema, psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder, none of the goods being for the treatment and detection of cervical cancer and related infections; plant extracts for medical use derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, epilepsy, arthritis, Crohn's Disease, insomnia, diabetes, eczema, psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder, none of the goods being for the treatment and detection of cervical cancer and related infections; plant extracts for pharmaceutical use derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, epilepsy, arthritis, Crohn's Disease, insomnia, diabetes, eczema, psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder, none of the goods being for the treatment and detection of cervical cancer and related infections; preparations for medical purposes derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, epilepsy, arthritis, Crohn's Disease, insomnia, diabetes, eczema, psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder, none of the goods being for the treatment and detection of cervical cancer and related infections; medical therapeutic agents derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, epilepsy, arthritis, Crohn's Disease, insomnia, diabetes, eczema, psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder, none of the goods being for the treatment and detection of cervical cancer and related infections; medical therapeutic creams derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, epilepsy, arthritis, Crohn's Disease, insomnia, diabetes, eczema, psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder, none of the goods being for the treatment and detection of cervical cancer and related infections; medical therapeutic drugs derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, epilepsy, arthritis, Crohn's Disease, insomnia, diabetes, eczema, psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder, none of the goods being for the treatment and detection of cervical cancer and related infections; natural healthcare preparations, namely, medicaments derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, epilepsy, arthritis, Crohn's Disease, insomnia, diabetes, eczema, psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder, none of the goods being for the treatment and detection of cervical cancer and related infections; natural pharmaceutical products derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, epilepsy, arthritis, Crohn's Disease, insomnia, diabetes, eczema, psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder, none of the goods being for the treatment and detection of cervical cancer and related infections; pharmaceutical preparations derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, epilepsy, arthritis, Crohn's Disease, insomnia, diabetes, eczema, psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder, none of the goods being for the treatment and detection of cervical cancer and related infections; pharmaceutical preparations for human use derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, epilepsy, arthritis, Crohn's Disease, insomnia, diabetes, eczema, psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder, none of the goods being for the treatment and detection of cervical cancer and related infections; pharmaceutical preparations for health care derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, epilepsy, arthritis, Crohn's Disease, insomnia, diabetes, eczema, psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder, none of the goods being for the treatment and detection of cervical cancer and related infections; pharmaceutical preparations for nasal use derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, epilepsy, arthritis, Crohn's Disease, insomnia, diabetes, eczema, psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder, none of the goods being for the treatment and detection of cervical cancer and related infections; pharmaceutical preparations for oral use derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, epilepsy, arthritis, Crohn's Disease, insomnia, diabetes, eczema, psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder, none of the goods being for the treatment and detection of cervical cancer and related infections; pharmaceutical preparations for topical use derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, epilepsy, arthritis, Crohn's Disease, insomnia, diabetes, eczema, psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder, none of the goods being for the treatment and detection of cervical cancer and related infections; pharmaceutical preparations and substances for the prevention, management and treatment of opioid addiction, cancer, namely, breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, epilepsy, arthritis, Crohn's disease, insomnia, diabetes, eczema, psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder, none of the goods being for the treatment and detection of cervical cancer and related infections; pain killers (pharmaceuticals), none of the goods being for the treatment and detection of cervical cancer and related infections; analgesic preparations, none of the goods being for the treatment and detection of cervical cancer and related infections; antibacterial preparations in the form of gels, hand lotions, handwashes, soap and wipes, none of the goods being for the treatment and detection of cervical cancer and related infections.


Classification kind code

11

Class [042]
Clinical trials, project management and planning of clinical trials, conducting clinical trials, research relating to pharmaceuticals, research relating to medicinal use of marijuana and cannabis, research and development of medicinal marijuana and cannabis products, medical research, medical research (scientific research for medical purposes), scientific research in the field of therapeutic medicinal cannabis, research relating to science in the field of therapeutic medicinal cannabis, provision of medical research services, none of the services being for the treatment and detection of cervical cancer and related infections.


Classification kind code

11

Mark Details


Serial Number

2017034

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 13th Jul 2021
Search Recorded
Submitted for opposition 256
on 12th Jan 2021
Notification of Possible Opposition Sent
Submitted for opposition 231
on 15th Oct 2020
Limitation
Submitted for opposition 236
on 14th Sep 2020
Partial Withdrawal - Madrid Protocol
Submitted for opposition 48
on 13th May 2020
Agent Changed
Submitted for opposition 257
on 12th Mar 2020
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 12th Mar 2020
Created
Submitted for opposition 31
on 12th Mar 2020
Formalized
Submitted for opposition 30
on 09th Jan 2020
Filed
Submitted for opposition 228
on 09th Jan 2020
International Registration